A phase 2 study of ARQ 501 in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck

Trial Profile

A phase 2 study of ARQ 501 in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Beta lapachone (Primary)
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Sponsors ArQule
  • Most Recent Events

    • 20 Mar 2008 Status changed from in progress to completed, in accordance with clinicaltrials.gov.
    • 05 Feb 2007 Status change from recruiting to in progress.
    • 23 Jan 2007 Trial centres added.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top